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Abstract
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity and mortality worldwide. A
growing body of evidence shows that individuals with COPD have important deficits in balance control that may be associated
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with an increased risk of falls. Pulmonary rehabilitation (PR) is a key therapeutic intervention for individuals with COPD; however,
current international guidelines do not include balance training and fall prevention strategies.
Objective: The primary aim of this trial is to determine the effects of PR with balance training compared to PR with no balance
training on the 12-month rate of falls in individuals with COPD. Secondary aims are to determine the effects of the intervention
on balance, balance confidence, and functional lower body strength, and to estimate the cost-effectiveness of the program.
Methods: A total of 400 individuals from nine PR centers across Canada, Europe, and Australia will be recruited to participate
in a randomized controlled trial. Individuals with COPD who have a self-reported decline in balance, a fall in the last 2 years, or
recent near fall will be randomly assigned to an intervention or control group. The intervention group will undergo tailored balance
training in addition to PR and will receive a personalized home-based balance program. The control group will receive usual PR
and a home program that does not include balance training. All participants will receive monthly phone calls to provide support
and collect health care utilization and loss of productivity data. Both groups will receive home visits at 3, 6, and 9 months to
ensure proper technique and progression of home exercise programs. The primary outcome will be incidence of falls at 12-month
follow-up. Falls will be measured using a standardized definition and recorded using monthly self-report fall diary calendars.
Participants will be asked to record falls and time spent performing their home exercise program on the fall diary calendars.
Completed calendars will be returned to the research centers in prepaid envelopes each month. Secondary measures collected by
a blinded assessor at baseline (pre-PR), post-PR, and 12-month follow-up will include clinical measures of balance, balance
confidence, functional lower body strength, and health status. The cost-effectiveness of the intervention group compared with
the control group will be evaluated using the incremental cost per number of falls averted and the incremental cost per
quality-adjusted life years gained.
Results: Recruitment for the study began in January 2017 and is anticipated to be complete by December 2019. Results are
expected to be available in 2020.
Conclusions: Findings from this study will improve our understanding of the effectiveness and resource uses of tailored balance
training for reducing falls in individuals with COPD. If effective, the intervention represents an opportunity to inform international
guidelines and health policy for PR in individuals with COPD who are at risk of falling.
Trial Registration: ClinicalTrials.gov NCT02995681; https://clinicaltrials.gov/ct2/show/NCT02995681 (Archived by WebCite
at http://www.webcitation.org/6ukhxgAsg)
(JMIR Res Protoc 2017;6(11):e228)   doi:10.2196/resprot.8178
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Introduction
Chronic obstructive pulmonary disease (COPD) is a major cause
of morbidity and mortality and is expected to be among the top
three causes of death in the world by the year 2020 [1]. As the
population ages, the prevalence of COPD is expected to increase,
which will impact health care resource utilization [1]. In 2010,
the Centers for Disease Control and Prevention reported the
medical costs attributable to having COPD were US $32.1
billion and by the year 2020, this is expected to increase to US
$49 billion [2].
Although treatment of COPD is often focused on respiratory
function, secondary impairments in skeletal muscle function,
mobility, and exercise capacity are well recognized [3-5]. There
is now strong evidence that individuals with COPD also have
important deficits in balance control and an increased risk of
falls [6-17], which has been linked to increased morbidity and
mortality in this population [18,19].
Balance impairment is widely recognized as one of the most
important modifiable risk factors for falls in older adults [20].
Numerous studies have documented impairments in clinical and
laboratory measures of balance in individuals with varying
COPD severity compared to controls [6,11,12,14-17,21,22].
Underlying mechanisms for reduced balance in COPD may
include decreased levels of physical activity [11,12], peripheral
muscle weakness [11], altered trunk muscle mechanics [16],
hypoxemia [23], and somatosensory deficits [24]. Our work has
also shown that individuals with COPD have a unique profile
of balance impairment, with marked deficits in three specific
subsystems of balance: biomechanics (ie, strength, range of
motion, and posture), transitions (ie, change in body positions),
and gait (ie, stability while walking) [17].
There is growing recognition of an increased fall risk in people
with COPD [7-10]. In addition to impaired balance, other fall
risk factors in COPD include the use of multiple medications,
muscle weakness, cognitive impairment, and comorbidities such
as osteoarthritis and osteoporosis [7]. COPD was second only
to osteoarthritis in its association with the number of falls in a
large cohort study of elderly women [9] and was the only
chronic condition that predicted falls in a further cohort study
of 16,000 participants [8]. Patients with COPD have reported
a higher prevalence of falls (40%-55%) [10,11,15,17] than the
general elderly population and in two prospective studies [7,10],
the annual fall rate in COPD was up to five times higher than
expected based on age alone. Fall-related injuries as well as
associated hospitalizations are also common in people with
COPD [18,25]. In those with more severe disease and
depression, a history of falling is a strong predictor of mortality
[19]. These data emphasize the need for the development of fall
prevention strategies specific to individuals with COPD.
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Pulmonary rehabilitation (PR) is recommended as standard
management for COPD as there is strong evidence for its effect
on improving symptoms, exercise tolerance, and health-related
quality of life [26-29]. The program typically consists of
supervised exercise training, disease-specific education,
self-management, and psychosocial support. While exercise is
viewed as the cornerstone of PR, it is largely focused on aerobic
exercise to increase endurance and resistance training.
International guidelines for PR do not include balance training
nor fall prevention strategies and few programs include a balance
assessment [26-31]. We have shown that the exercise component
of conventional PR has only minimal effect on measures of
balance and fall risk [32]. Therefore, to reduce falls, exercise
that includes targeted balance training is needed [33]. We
recently undertook a pilot randomized controlled trial (RCT)
[34] to examine the effects of adding balance training alongside
PR, which specifically addressed the unique profile of balance
deficits we had identified in COPD [17]. We reported large and
clinically important improvements in balance performance
among those in the intervention group compared to controls
who completed typical PR [34]. We have also found such an
intervention to be easily implementable into clinical practice
[35]. This study builds on our existing experience to rigorously
test the effect of the intervention on balance and fall reduction
in individuals with COPD.
The objectives of this study are to (1) evaluate the long-term
effects of a tailored, balance exercise program on the 12-month
rate of falls in individuals with COPD who are enrolled in
outpatient PR compared to PR with balance exercise training;
(2) determine the effects of a tailored, balance exercise program
on the secondary outcomes, including measures of balance,
balance confidence, and functional lower body strength; and
(3) conduct an economic analysis to evaluate the
cost-effectiveness of the program compared to PR with no
balance training.
Methods
Ethics
The protocol has received ethics approval from the Joint West
Park Healthcare Centre/Toronto Central Community Care
Access Centre/Toronto Grace Health Centre Research Ethics
Board (REB) (Canada); the University of Toronto REB
(Canada); the Nova Scotia Health Authority REB (Canada); the
University of Aveiro REB (Portugal); the University of British
Columbia/Providence Health Care REB (Canada); the National
Health Service REB (United Kingdom); the University of
Alberta REB (Canada); the Alfred Health REB (Australia); the
Royal Prince Alfred Hospital REB (Australia); and the Western
Health REB (Australia).
Adverse events will be collected after individuals have consented
and been enrolled in the study. Adverse events that meet the
criteria for a serious adverse event (SAE) will be reported to
the local REB. An SAE is defined as any adverse event that
results in the following patient outcomes: death, life-threatening
condition, hospitalization (initial/ prolonged), disability/
permanent damage, intervention required to prevent permanent
impairment or damage, or any other medically important event
[36].
Formal amendments will be submitted to each REB in
consultation with local investigators should there be any
modifications to the protocol. Modifications to the protocol will
be final and agreed upon by all investigators before amendment
applications are submitted.
Trial Registration and Reporting
The trial is registered with ClinicalTrials.gov (NCT02995681)
and our protocol is reported according to the Standard Protocol
Items: Recommendation for Intervention Trials (SPIRIT)
checklist [37].
Study Design
We will conduct a multi-center RCT with allocation concealment
as well as blinding of the outcome assessors and data analysts
to group allocation. A participant flowchart is outlined in Figure
1.
Setting
Outpatient PR programs at nine sites across four
countries—Canada, United Kingdom, Portugal, and
Australia—are participating in the study. PR programs in
Canada, United Kingdom, and Australia are publicly funded
through government-run health plans. PR programs in Portugal
are only partially funded by the government.
Participants
Individuals will be considered eligible for the study if they meet
the following inclusion criteria: (1) have a diagnosis of COPD
based on the Global Initiative for Chronic Obstructive Lung
Disease (GOLD) criteria—postbronchodilator forced expiratory
volume in 1 second (FEV1)/forced vital capacity (FVC) ratio
<70% [38]; (2) have a self-reported decline in balance, a fall in
the last 2 years, or a recent near fall; and (3) are able to provide
written informed consent.
Individuals will be excluded if they meet the following exclusion
criteria: (1) are unable to communicate because of language
skills (eg, communication deficit; non-English speaking in
Canada, United Kingdom, or Australia; or non-Portuguese
speaking in Portugal); (2) are hearing or cognitively impaired
(eg, dementia or neurological condition); or (3) have evidence
of a neurological or musculoskeletal condition that severely
limits mobility and postural control (eg, cerebrovascular
accident, Parkinson’s disease, or lower limb amputee).
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Figure 1. Participant flow diagram. PR: pulmonary rehabilitation.
Recruitment
Individuals will be recruited upon enrolment in PR programs
at each participating site. Study information sheets were
developed specific to each site and translated as required. A
member of the research team not involved in the individual’s
clinical care will meet with potential participants to provide
information about the study. If the individual agrees to
participate, written informed consent will be obtained.
Recruitment will continue until the overall target population
size is reached for the study. Each clinical site involved in the
trial was selected based on investigator expertise and data on
previous experience with study recruitment rates.
Retention
Participants may withdraw from the study for any reason at any
time. Investigators may also withdraw participants from the
study if they demonstrate a sudden and severe deterioration in
balance (eg, due to dizziness from a medication change or a
newly diagnosed medical condition) that would jeopardize their
safety during balance training.
Every effort will be made to perform study assessments on
individuals who withdraw from the study or who do not
sufficiently adhere to the usual care or intervention protocols.
Allocation
A computer-generated block randomization table will be created
by a member of the research team not involved in recruitment.
A randomization schedule will be provided for each site. After
an individual has been enrolled in the study and the baseline
assessment has been completed, the central research coordinator
will consecutively allocate participants using sealed opaque
envelopes and advise each site coordinator of group allocation.
Intervention
Control: Usual Care
Participants randomized to the control group will receive usual
outpatient PR. The PR programs across the nine sites are given
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two to three times per week for a total duration of 8-12 weeks
depending on the site. All PR programs are offered in
accordance with international guidelines [26-29,31] and consist
of all core components of rehabilitation including aerobic and
resistance exercise, self-management education, and
psychosocial support.
Upon discharge from outpatient PR, participants will receive
the usual individualized home-based exercise program which
will include walking and lower extremity resistance exercises
two to three times a week. To control for attention between the
two groups and maximize data collection, in addition to usual
care, participants will receive monthly phone calls from a
physiotherapist to provide support and problem solve any issues,
as well as home visits at 3, 6, and 9 months.
Intervention: Tailored Balance Training
Participants randomized to the intervention group will receive
a 30-minute balance training session twice per week in addition
to usual PR, and will be asked to complete a third session at
home each week, for a total of 90 minutes of balance training
per week. This is in keeping with best practice guidelines for
older adults and the design of our previous RCT in COPD
[32,35,39]. The balance exercises (see Multimedia Appendix
1) will be tailored to emphasize the areas found to be most
deficient in COPD [17]. Participants will receive balance
training in a separate location or at a separate time from the
control group. Sessions will be supervised by physiotherapists
using a circuit training approach. While participants may work
through stations in groups, each participant will receive
individualized exercise prescription based on their baseline
balance assessment, as well as recommendations for
individualized exercise progression. Our previous trial
demonstrated the feasibility of this approach [34]. Participants
will also receive an instruction booklet that outlines their
individual exercises for the once-weekly, home-based balance
training session during PR.
After completion of PR, participants will complete the
prescribed home-based balance training program three times
per week. The home-based program will follow for the duration
of the 12-month follow-up period.
Participants will receive monthly phone calls from their
physiotherapist to provide support and problem solve any issues,
as well as home visits at 3, 6, and 9 months to ensure proper
technique and progression at home.
Outcomes
Outcome measures will be collected by a blinded assessor at
baseline, at the end of PR, and at 12-month follow-up.
Primary Outcome
The primary outcome measure will be incidence of falls at
12-month follow-up. A fall will be defined as “an incident in
which the body unintentionally comes to rest on the ground or
other lower level which is not as a result of a violent blow, loss
of consciousness, sudden onset of paralysis as in a stroke or an
epileptic seizure” [40]. Based on published consensus [41], the
participants will be asked, “Have you had any fall including a
slip or trip in which you lost your balance and landed on the
floor or ground or lower level?” Falls will be measured using
monthly fall diary calendars, which are the recommended
methodology for falls reporting in clinical trials [41]. All
participants will receive the fall diary calendars at the time of
the baseline assessment.
Participants will be asked to record falls and time spent
performing their home exercise program on the fall diary
calendars. They will also be asked to contact the research
assistant in the event of a fall or health-related event to ensure
all relevant information is included and to return completed
diaries in prepaid envelopes to the research center each month.
Participants who do not return the calendars or those with
unclear data will be telephoned to collect the information.
Secondary Outcomes
Clinical Measures of Balance
The Berg Balance Scale (BBS) [42] is one of the most widely
used and psychometrically robust clinical measures of balance
for older adults. It assesses 14 tasks such as transfers, reaching,
turning around, and single-legged stance. Evidence supports
the BBS’s construct validity and sensitivity to change following
PR in individuals with COPD [43]. Test-retest reliability and
predictive validity for fall risk have been demonstrated in
community-dwelling older adults [44]. The total score is out of
56 with higher scores indicating better balance. Among patients
with moderate to severe COPD undergoing PR, a change of 5-7
points is clinically important [45].
The Balance Evaluation Systems Test (BESTest) [46] is a
comprehensive 36-item balance evaluation tool that assesses
six subsystems of balance control: biomechanics, stability
limits/verticality, anticipatory postural adjustments for postural
transitions, reactive postural response strategies, weighting of
sensory information, and postural stability during gait. Evidence
supports the BESTest’s construct validity in COPD [43] and
sensitivity to change, as well as test-retest reliability and
concurrent validity in adults with and without balance disorders
[46]. Total scores range from 0% to 100% and a change of 13-17
points on the BESTest is clinically important in patients with
COPD [45].
Balance Confidence
The Activities-Specific Balance Confidence (ABC) scale [47]
requires patients to indicate their confidence in performing 16
activities without losing their balance or becoming unsteady.
The ABC scale has good test-retest reliability and predicts falls
in older adults residing in the community [41,44]. In patients
with COPD, the ABC scale has demonstrated construct validity
as well as criterion validity for falls [43]. Total scores range
from 0% to 100% with higher scores for better balance
confidence. A change of 19% reflects a clinically important
difference for this measure in COPD [45].
Functional Lower Body Strength
The 30-second repeated chair stand test [48] will be used as a
measure of functional lower body strength. The reliability and
validity of this measure has been established in people with
COPD and the measure is correlated to maximal voluntary force
from a seated leg press [49]. The repeated chair stand test is
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sensitive to change after balance training in people with COPD
[34].
Descriptive Measures
Descriptive measures will include sociodemographic variables
(gender, age), anthropometry (height, weight, body mass index),
smoking history, oxygen use, rollator walker use, spirometry
measures (FEV1, FVC, FEV1/FVC ratio, FEV1% predicted,
FVC % predicted), a measure of exercise tolerance (6-minute
walk test [6MWT]) [50], comorbid conditions, and medication
use. We will also use the Baseline Dyspnea Index (BDI) [51]
and the Falls Risk for Older People-Community setting
(FROP-Com) [52] to further characterize the study sample. A
home exercise log will be used to describe participant
self-reported adherence to the intervention.
Health Status
Health status is an important patient-reported outcome that
describes health-related quality of life of patients. The European
Quality of Life 5-Dimension Questionnaire (EQ-5D-5L) will
be used to measure health status. It consists of five questions
covering dimensions of mobility, self-care, usual activities,
pain/discomfort, and anxiety/depression with five response
options indicating no, mild, moderate, severe, and extreme
problems for each dimension [53]. The answers to the five
questions included in this instrument can be converted to health
utility which is an index score anchored at 0 (equivalent to dead)
and 1 (for full health), with negative scores for worse than dead.
The EQ-5D-5L-derived health utilities will be calculated using
the recently developed scoring algorithm for Canada [54] and
United Kingdom [55] and the interim algorithm for Australia
and Portugal [56]. The EQ-5D-5L will be administered at
baseline and at 6- and 12-month follow-up, and then used to
determine quality-adjusted life years (QALY) for each
respondent. For this study, the resulting adjustment is an
adjustment on quality of life as we do not anticipate any
differences in survival.
Economic Analysis
An economic analysis will be conducted alongside the trial
using the primary outcome (ie, number of falls) and health
utilities as effect measures. We will use methods consistent with
standard texts and guidelines for economic evaluation [57]. The
time horizon of the analysis will be the period of study follow-up
(ie, 12 months). Both societal and health care payers’
perspectives will be used for the analysis.
Health care resource utilization and loss of productivity related
to falls and COPD will be collected during monthly phone calls
to participants. During the monthly phone calls, the participants
will be asked if they have had any health care appointments (ie,
family doctor, walk-in/urgent care clinic, or specialist),
emergency room visits, or hospital stays related to having COPD
or a fall. If the participant responds “yes,” the physiotherapist
will then ask for details about which health care professionals
were seen; what tests, medications, or treatments were ordered;
and, if they were hospitalized, for how long.
The time it takes for therapists to administer the rehabilitation
exercises, monthly phone calls, and home visits in both
intervention and control groups will also be recorded. These
resource utilizations will be converted to direct medical costs
using country-specific unit costs. Indirect costs may include the
productivity loss for patients, if still working, or family members
who provide care/assistance to the participating patient.
Data Collection
All subject data will be deidentified and coded with a unique
study identifier. Data collection forms and digital files will be
securely stored as per the REB protocols.
Each site will be responsible for entering deidentified participant
data into a digital database and securely sharing it with the lead
investigators and central data analyst for analysis. Only the lead
investigators and central data analyst will have access to the
final dataset.
A data monitoring committee will be set up to monitor the trial
for possible harmful effects. The committee will evaluate any
adverse events to recommend whether the study should continue,
be modified, or stopped due to safety concerns.
Data Analysis
The data analysts on the research team will be blinded to group
allocation. Descriptive summary statistics will be reported using
mean, median, and standard deviation for continuous measures,
and frequency and counts for categorical variables. For the
primary outcome, we will use random effect Poisson (Negative
Binomial) regression model to compare the number of falls at
12-month follow-up between intervention and control groups
adjusting for potential confounders, repeated measures, and
clustering of participants within centers. For secondary
outcomes, we will use random effect linear regression to
compare intervention and control groups adjusting for potential
confounders and clustering of the observations. For all measures,
we will perform intention-to-treat and per protocol analysis.
We will estimate the total cost for the intervention and control
groups and calculate the difference between the two groups.
Similarly, for the effect measures, we will calculate the
difference in the number of falls and in the QALY between
groups. The summary measure for the economic analysis will
be the incremental cost per number of falls averted
(cost-effectiveness analysis) and the incremental cost per QALY
gained (cost-utility analysis) for the intervention group compared
with the control. Given that this economic analysis will be using
data primarily from study participants, nonparametric bootstrap
will be used to calculate the 95% confidence interval around
the incremental ratios. The decision uncertainty will be presented
using cost-effectiveness acceptability curves that show the
probability of the intervention being cost-effective compared
with the control group at a wide range of willingness to pay for
a QALY [57].
No interim or subgroup analysis is planned. We will perform
both intention-to-treat and per protocol analyses.
Sample Size Calculation
First, we calculated the sample size for an individually
randomized two-arm study with 80% power and 5% type I error.
We estimated the rate of falls for the control group as 120 per
100-person years, consistent with prospective studies
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documenting fall rates in similar populations of patients with
COPD in Canada and Australia [7,10]; the rate of falls in the
intervention group was estimated as 84 per 100-person years,
which corresponds to a 30% reduction in the rate of falls. A
30% reduction in fall rate is widely used as a clinically
significant threshold in fall prevention studies and is consistent
with meta-analyses demonstrating the effect of multi-component
exercise on fall rate. Based on this data, the estimated number
of participants in each arm with 1-year follow up is 124 patients.
However, our study is a multicenter study in which participants
are clustered within nine centers. Assuming a coefficient of
variation of size 0.10, we need, on average, 19 participants in
each arm per site, corresponding to a total of 171 participants
in each arm, to account for the clustering of the study [58].
Assuming a similar clustering effect for the secondary outcomes
with a sample size of 171 participants in each arm and nine
centers, our study has 80% power with 5% type I error to detect
differences of the following magnitudes (MCID: minimal
clinically important difference):
1. Berg Balance (SD=6.15, MCID=5) differences of 3.0 units
or larger.
2. BESTest (SD=13, MCID=13) differences of 6.4 units or
larger.
3. ABC (SD=23.2, MCID=19) differences of 11.5 units or
larger.
4. Chair stand (SD=4.8, MCID=3) differences of 2.4 units or
larger.
These values are close to half the standard deviation of the
outcome measures and are sufficient to detect clinically
important changes [45].
We anticipate a loss to follow-up of 15%-20% based on previous
trials in PR and have inflated our sample size to 400 participants
(200 in each arm) to account for this. Should a participant be
unable to attend an assessment session at a study center, we will
minimize loss to follow-up by offering to complete assessments
in the participants’ homes.
Results
A Canadian Institutes of Health Research (CIHR) project grant
was received to fund the study. Recruitment began in January
2017 and is anticipated to be completed by December 2019.
Results are expected to be available in 2020.
Discussion
Principal Findings
The high incidence of falls and balance problems in people with
COPD underscores the need for evidence-based approaches to
fall prevention in this population. While studies have shown
that balance training alongside PR improves measures of balance
and mobility, the long-term impact on falls has not been
determined. This international multi-center trial will be the first
RCT of tailored balance training in people with COPD who are
enrolled in outpatient PR. It is also the first study of balance
training that includes an economic analysis to consider the
cost-effectiveness of the intervention.
If participation in tailored balance training does decrease falls
compared to usual PR, this approach will represent an innovative
and potentially cost-saving strategy to prevent falls and reduce
health care utilization in COPD. Our results will be relevant for
guiding clinical and policy-based decision-making, given the
high prevalence of COPD and potential for severe consequences
of falls in this population.
Conclusions
In conclusion, this study will provide evidence on the
effectiveness of tailored balance training for individuals with
COPD who have a history of falling or a self-reported decline
in balance skills. If effective, the results of this study could be
used to inform future international guidelines and health policy
for PR in this population.
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